Amgen(AMGN)
Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. One of the world's largest independent biotechnology companies, Amgen was established in Thousand Oaks, California, in 1980. Amgen's Thousand Oaks staff in 2017 numbered 5,125 (7.5% of total city employment) and included hundreds of scientists, making Amgen the largest employer in Ventura County. Focused on molecular biology and biochemistry, its goal is to provide a healthcare business based on recombinant DNA technology.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
Mock data
Subscribe for the real data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name | Drug Name | Approved | Patent Expires | Indication |
|---|---|---|---|---|
| Aimovig | Erenumab | 2018-05-17 | ||
| Amgevita | Adalimumab | 2017-03-21 | ||
| Amjevita | Adalimumab | 2016-09-23 | ||
| Aranesp | Darbepoetin, Darbepoetin alfa | 2001-09-17 | ||
| Avsola | Infliximab | 2019-12-06 | ||
| Blincyto | Blinatumomab | 2014-12-03 | ||
| Corlanor | Ivabradine | 2015-04-15 | 2026 | |
| Epogen/procrit | Epoetin alfa | 1989-06-01 | ||
| Evenity | Romosozumab | 2019-04-09 | ||
| Imlygic | Talimogene laherparepvec | 2015-10-27 | ||
| Kanjinti | Trastuzumab | 2019-06-13 |
1
2
3
>
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Indication |
|---|---|---|---|---|---|
1
2
3
4
5
6
...
8
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use